1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pembrolizumab + MRGOO3 as Neoadjuvant in NPCnasopharyngeal carcinomaNot yet recruitingPhase 22025-12-05NCT07267338